돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1806235생성일: 2026년 10월 26일

Dihydroxybenzylamine → 5-[3-({[(3,4-dihydroxyphenyl)methyl]amino}methyl)phenyl]-3-[1-(ethylsulfonyl)-4-piperidinyl]-1H-indole-7-carboxamide

https://huagongshe.com/reaction/1806235

반응식

참여 물질

역할이름HCID투입량
반응물DihydroxybenzylamineHCID 91623—
반응물Sodium triacetoxyborohydrideHCID 5049666—
반응물3-[1-(ethylsulfonyl)-4-piperidinyl]-5-(3-formylphenyl)-1H-indole-7-carboxamideHCID 57732804—
용매1,1-DichloroethaneHCID 6365—
생성물5-[3-({[(3,4-dihydroxyphenyl)methyl]amino}methyl)phenyl]-3-[1-(ethylsulfonyl)-4-piperidinyl]-1H-indole-7-carboxamideHCID 1603820315.1%

반응 단계

To a solution of 3-[1-(ethylsulfonyl)-4-piperidinyl]-5-(3-formylphenyl)-1H-indole-7-carboxamide (50 mg, 0.114 mmol) in dichloroethane (2 mL) was added 4-(aminomethyl)-1,2-benzenediol (12.1 mg, 0.087 mmol). The reaction solution was stirred at ambient temperature for 10 min prior to addition of NaBH(OAc)3 (58 mg, 0.261 mmol). The resulting mixture was shaken overnight at ambient temperature after which time the solvent was removed under reduced pressure. The crude product was purified by reverse phase HPLC (water/CH3CN, 0.1% TFA 10-90%) to give the title compound (7.4 mg, 12%).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08354406B2
출처 데이터셋uspto-grants-2013_01
ORD IDord-16a06a40570c43ab95fa819c4bcc2391
출처 메모uspto-grants-2013_01